MTFs, advanced charts, advisory & more—right at your fingertips.
Invest in top performing funds at 0% commission
Apply for IPOs within few clicks!
Invest in fixed-income instrument with low risk
Enjoy easy diversification with flexible investment
Invest in top US stocks
Trade F&O contracts across segments along with far expiry contracts
Diversify your portfolios beyond traditional securities
A go-to app for traders and investors.
A desktop platform designed to execute trades at lightning fast speed.
A trading terminal designed exclusively for derivatives traders.
Go-to platform for the fast and flexible traders.
Build your own trading terminal for FREE.
Trade directly from TradingView charts with Tv.5paisa.
Embed 5paisa trading button to your website.
Trade like a pro - Access charts, Analyse Patterns and Execute Orders.
30th Oct 2021
In the light of the Templeton fiasco last April and the subsequent SEBI order on the role ostensibly played by the senior managers of the fund, SEBI has opted to tighten the screws. It has barred employees and directors of AMCs and trustees of the fu
In a high level meeting between the top officials of the IRCTC and the Railway Board, the Ministry of Railways decided to withdraw the decision to ask IRCTC to share 50% of the convenience fee charged from customers on online ticketing. The new rule
29th Oct 2021
Exide Industries Ltd - Q2 Results Exide Industries Ltd has posted a healthy 18.62% growth in total revenues for the Sep-21 second quarter of the fiscal at Rs.4,758 crore. Even if you look at revenues on a sequential basis, the revenues were higher
It may be recollected that last year when Reliance had come out with its Rs.53,124 crore rights issue, the allotment money was payable in three tranches over a period of 18 months. As a result, during this period, the Reliance stock had dual trading
Dr. Reddy's Laboratories - Q2 Results Dr. Reddy's Laboratories Ltd reported stellar numbers for the September 2021 quarter as its top line revenues grew by 17.7% at Rs.4,987 crore. Even on a quarter on quarter basis, the revenues were higher by
28th Oct 2021
Samvat 2077 has given investors multiple reasons to cheer. Both the benchmark indices – Sensex and Nifty surged over 50% each, gazing beyond the transitory pain arising from the pandemic. Broader markets, however, outperformed the benchmark indices
27th Oct 2021
The most recent entrant to the mutual fund space, NJ India Mutual Fund has raised a record Rs.5,200 crore from its maiden NFO of the NJ Balanced Advantage Fund. This is the highest amount ever collected by any maiden NFO by any fund. NJ has been one
Muhurat Trading 2021 - Samvat 2078 The history of Muhurat trading is almost as old as the Bombay Stock Exchange itself. The business community from Gujarat and Rajasthan, that has traditionally dominated the stock exchange membership and trad
Sunil Singhania needs no introduction in stock market circles. As the CIO of Reliance Mutual Fund, Sunil worked closely with Madhu Kela to make Reliance Mutual Fund a formidable name in the mutual fund industry. Sunil Singhania currently runs the Aba
On 26th October, two important companies in the healthcare space viz. Cipla and Dr. Lal Pathlabs announced their quarterly results. Here is a gist of the numbers. Cipla Ltd - Q2 Results Cipla Ltd reported 9.56% higher sales for the Se
26th Oct 2021
On 26th October, 3 heavyweight financials announced their results viz. Axis Bank, Kotak Bank and Bajaj Finance. Here is a gist of the 3 results announcements. Axis Bank - Q2 Results Axis Bank reported 4.17% increase in revenues in the S
Almost a week after Vodafone Idea signed up for the 4 year moratorium, Bharti Airtel has also signed up for the moratorium. While Vodafone Idea had only signed up for moratorium on the spectrum dues, Bharti Airtel has signed up with DOT for moratoriu
Be a part of 5paisa community - The first listed discount broker of India.
Open Free Demat Account in mins